Successful treatment with oral steroid and hydroxychloroquine in a patient with systemic lupus erythematosus upon COVID‐19 infection: A case report with detailed laboratory data

The administration of glucocorticoid and hydroxychloroquine (HCQ) may be able to control systemic lupus erythematosus (SLE) activities under COVID‐19 infection by suppress the cytokine storm.

Detalles Bibliográficos
Autores principales: Kondo, Makoto, Matsushima, Yoshiaki, Iida, Shohei, Umaoka, Ai, Nakanishi, Takehisa, Habe, Koji, Yamanaka, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385256/
https://www.ncbi.nlm.nih.gov/pubmed/34466256
http://dx.doi.org/10.1002/ccr3.4700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385256/
https://www.ncbi.nlm.nih.gov/pubmed/34466256
http://dx.doi.org/10.1002/ccr3.4700

Ejemplares similares